蕲蛇酶治疗急性脑梗死临床疗效观察  

Clinical Observation of Acutobin Treating Acute Cerebral Infarction

作　　者：闫建萍 邱德胜 

机构地区：[1]福建省龙岩人民医院神经内科,福建龙岩364000

出　　处：《蛇志》2002年第3期32-33,共2页Journal of Snake

摘　　要：目的　观察蕲蛇酶治疗急性脑梗死的临床疗效和安全性。　方法　治疗组 10 0例 ,用蕲蛇酶治疗 ;对照组 50例 ,用常规药物治疗 ,观察两组临床疗效及副作用。　结果　蕲蛇酶治疗组治疗 14天后疗效明显优于对照组 ,蕲蛇酶组纤维蛋白原明显下降 ,有 2例有出血现象。　结论　蕲蛇酶是治疗急性脑梗死疗效确切 。Objective To observe efficacy and safety of acutobin in treatment of acute cerebral infraction Methods 100 patients (acutobin group)with acute cerebral infarction was treated by acutobin,50 patients (control group) was treated by the common used drugs, Curative efficacy and side effects of acutobin were estimated and observed Resucts The efficacy of acutobin group was singificantly higher than that of contral group after the treating on the 14h day The plasma fibrinogen decreased obviously ,Two bleeding and clear side effects were found Conclution Acutobin can be a safe and effective drug in treatment of acute cerebral infarction

关 键 词：蕲蛇酶 治疗 急性脑梗死 临床疗效 安全性 

分 类 号：R743.05[医药卫生—神经病学与精神病学] R973.2[医药卫生—临床医学]